Nicholas J Vogelzang Selected Research

5,6-dihydro-5-azacytidine

4/2008

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas J Vogelzang Research Topics

Disease

109	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 02/2002
83	Neoplasms (Cancer) 01/2022 - 01/2002
54	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 02/2002
32	Carcinoma (Carcinomatosis) 01/2022 - 02/2002
25	Neoplasm Metastasis (Metastasis) 06/2018 - 08/2003
20	Disease Progression 01/2022 - 03/2003
16	Leukemia 02/2011 - 02/2002
15	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 02/2002
14	Circulating Neoplastic Cells 01/2021 - 06/2009
14	Malignant Mesothelioma 10/2019 - 01/2002
13	Pain (Aches) 01/2019 - 01/2004
10	Neutropenia 01/2020 - 01/2002
9	Fatigue 01/2022 - 01/2004
9	Kidney Neoplasms (Kidney Cancer) 10/2021 - 06/2003
8	Adenocarcinoma 02/2012 - 02/2003
6	Thrombocytopenia (Thrombopenia) 03/2018 - 02/2002
6	Mesothelioma 01/2017 - 02/2002
6	Transitional Cell Carcinoma 02/2013 - 04/2005
5	Diarrhea 01/2022 - 01/2004
5	Anemia 01/2020 - 05/2003
5	Hypertension (High Blood Pressure) 10/2019 - 05/2010
3	Melanoma (Melanoma, Malignant) 01/2021 - 09/2011

Drug/Important Bio-Agent (IBA)

40	Hormones (Hormone)IBA 10/2022 - 02/2002
37	AndrogensIBA 10/2022 - 07/2003
34	Docetaxel (Taxotere)FDA Link 07/2022 - 12/2003
27	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 04/2002
23	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2002
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2004
14	Gemcitabine FDA Link 01/2021 - 01/2002
11	Radium-223IBA 10/2022 - 04/2014
11	PlatinumIBA 01/2021 - 09/2010
11	Sunitinib (Sutent)FDA Link 01/2021 - 02/2007
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 12/2002
10	Tyrosine Kinase InhibitorsIBA 01/2019 - 07/2008
9	Pemetrexed (MTA)FDA Link 10/2019 - 02/2002
8	Everolimus FDA Link 12/2021 - 06/2013
8	Pharmaceutical PreparationsIBA 01/2021 - 07/2004
8	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2006
7	pembrolizumabIBA 01/2022 - 01/2017
7	atezolizumabIBA 01/2021 - 11/2014
7	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 06/2007
7	TOR Serine-Threonine KinasesIBA 01/2016 - 12/2012
7	Methotrexate (Mexate)FDA LinkGeneric 09/2011 - 02/2002
6	B7-H1 AntigenIBA 01/2022 - 11/2014
6	Prednisone (Sone)FDA LinkGeneric 01/2022 - 05/2012
6	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2002
6	pazopanib FDA Link 01/2020 - 06/2015
6	cabozantinibIBA 01/2019 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2004
6	AtrasentanIBA 01/2017 - 02/2003
6	Hemoglobins (Hemoglobin)IBA 01/2017 - 04/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011 - 08/2003
6	Suramin (Suramin Sodium)IBA 06/2006 - 07/2002
5	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 07/2003
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2003
5	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2015
5	NivolumabIBA 12/2020 - 03/2017
5	Testosterone (Sustanon)FDA Link 12/2020 - 08/2004
5	Monoclonal AntibodiesIBA 01/2020 - 03/2004
5	sipuleucel-T (APC8015)FDA Link 01/2020 - 02/2012
5	Axitinib (AG 013736)IBA 01/2019 - 12/2013
5	Interleukin-2 (IL2)IBA 12/2015 - 05/2002
5	Androgen Antagonists (Antiandrogens)IBA 04/2013 - 07/2003
5	Complementary DNA (cDNA)IBA 02/2012 - 01/2004
5	Vinblastine (Vinblastine Sulfate)FDA Link 09/2011 - 08/2003
4	abirateroneIBA 10/2022 - 10/2012
4	bicalutamide (Casodex)FDA LinkGeneric 10/2022 - 10/2005
4	Angiogenesis InhibitorsIBA 10/2019 - 05/2004
4	Phosphotransferases (Kinase)IBA 01/2019 - 04/2014
4	VaccinesIBA 03/2017 - 09/2011
4	EnzymesIBA 03/2016 - 01/2004
4	Alkaline PhosphataseIBA 01/2016 - 03/2003
4	MTOR InhibitorsIBA 11/2014 - 12/2012
4	temsirolimus FDA Link 11/2014 - 06/2007
4	Estramustine FDA Link 05/2011 - 12/2003
4	Ketoconazole (Nizoral)FDA LinkGeneric 11/2007 - 03/2004
4	Cytotoxins (Cytolysins)IBA 10/2005 - 12/2002
3	enzalutamideIBA 07/2022 - 09/2012
3	rucaparibIBA 12/2021 - 01/2020
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 01/2020
3	lenvatinibIBA 12/2021 - 01/2019
3	vinflunineIBA 01/2021 - 01/2017
3	durvalumabIBA 10/2020 - 03/2017
3	cixutumumabIBA 01/2020 - 05/2015
3	AntigensIBA 01/2020 - 09/2011
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 01/2017
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 12/2002
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 02/2013
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2002

Therapy/Procedure

95	Therapeutics 10/2022 - 01/2002
57	Castration 10/2022 - 08/2004
46	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
16	Immunotherapy 01/2022 - 02/2004
8	Radiotherapy 05/2017 - 12/2002
5	Nephrectomy 08/2019 - 02/2004
5	Neoadjuvant Therapy 07/2014 - 08/2003
5	Cystectomy 01/2014 - 08/2003
4	Prostatectomy (Retropubic Prostatectomy) 01/2018 - 02/2007
4	Combination Drug Therapy (Combination Chemotherapy) 09/2011 - 06/2003
3	Aftercare (After-Treatment) 01/2021 - 11/2004